2026年全球藥物篩檢市場報告

近年來，藥物篩檢市場發展迅速，預計將從2025年的97.2億美元成長到2026年的111.8億美元，複合年成長率達15.0%。過去幾年的成長可歸因於職場藥物檢測項目的增加、臨床試驗活動的擴展、執法機關篩檢要求的提高、診斷檢查室的成長以及快速檢測套組的日益普及。

預計未來幾年，藥物篩檢市場規模將快速成長，到2030年將達到192億美元，複合年成長率（CAGR）為14.5%。預測期內的成長可歸因於人工智慧驅動的篩檢分析技術的日益普及、攜帶式藥物檢測設備需求的成長、監管藥物合規性檢測的擴展、即時報告系統的廣泛應用以及多組藥物篩檢的創新。預測期內的關鍵趨勢包括快速藥物檢測套組的日益普及、自動化檢查室篩檢系統的使用日益增多、數位化報告解決方案的日益整合、照護現場藥物檢測的擴展以及對高精度檢測的日益重視。

藥物篩檢市場的成長預計將受到毒品和酒精消費量不斷上升趨勢的推動。藥物成癮是一種影響大腦和行為的疾病，會導致人們不受控制地使用合法和非法物質，例如酒精、大麻和尼古丁。隨著藥物和酒精成癮的加劇，相關的健康風險也隨之增加，這必然會催生對藥物篩檢的需求。例如，根據聯合國毒品犯罪防制署（UNODC）於2025年6月發布的報告，到2023年，將有3.16億人使用毒品（不包括酒精和菸草），佔15至64歲人口的6%。大麻仍然是使用最廣泛的毒品，使用者達2.44億，其次是鴉片類藥物（6100萬）、安非他命（3070萬）、可卡因（2500萬）和搖頭丸（2100萬）。報導警告稱，逃離困境、動盪和衝突的新弱勢群體可能會進一步推高這些數字。持續的新冠疫情進一步加劇了毒品風險，某些地區年輕人的大麻消費量增加了近四倍。毒品和酒精消費量的上升是推動藥物篩檢市場成長的主要因素。

在藥物篩檢市場中營運的公司越來越重視策略夥伴關係和合作，以增強其財務基礎、拓展產品線並擴大地域覆蓋範圍。策略聯盟是指兩個或多個獨立組織之間達成的協議，旨在共同追求既定目標，同時維持營運自主性。例如，2025年2月，加拿大藥物檢測公司Neopharma Technologies和美國認知評估公司Impairment Science宣佈建立策略聯盟，以推動藥物和認知障礙檢測技術的發展。此次合作將整合Neopharma的NEOVAULT平台（該平台可對快速藥物檢測結果進行數位分析與報告）與Impairment Science的DRUID認知障礙評估系統（一款基於人工智慧的認知障礙評估工具）。透過結合這些技術，此次合作旨在提供關於藥物檢測和認知障礙的即時洞察，從而提高藥物篩檢的準確性和實用性。這項措施可望透過人工智慧和數位化報告解決方案，改善職場安全、支援合規性，並提升安全關鍵環境中的決策水準。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球藥物篩檢市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施和互聯生態系統
  • 生物技術、基因組學和精準醫學
• 主要趨勢
  • 擴大快速藥物檢測套組的引入
  • 擴大自動化檢測系統的應用
  • 數位化報告解決方案的整合度不斷提高
  • 擴大照護現場藥物檢測
  • 人們越來越關注高精度檢測

第5章 終端用戶產業市場分析

• 藥物檢測實驗室
• 職場
• 醫院
• 執法機關
• 藥物治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球藥物篩檢市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球藥物篩檢市場規模、對比及成長率分析
• 全球藥物篩檢市場表現：規模與成長，2020-2025年
• 全球藥物篩檢市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 快速檢測設備、耗材及其他產品
• 依檢體類型
• 口腔液樣本、毛髮樣本、尿液樣本、呼氣樣本和其他樣本類型
• 最終用戶
• 藥物檢測實驗室、職場、刑事司法和執法機關、醫院、戒毒中心、個人藥物使用者、疼痛管理中心、學校和學院
• 按類型細分：快速檢測設備
• 尿液藥物檢測套組、唾液藥物檢測套組、血液藥物檢測儀、即時檢測試紙
• 按類型細分：消耗品
• 試劑及檢測方法、檢體採集檢體、校正標準品
• 按類型細分：其他產品
• 實驗室設備、軟體解決方案、儲存和運輸解決方案

第10章 區域與國家分析

• 全球藥物篩檢市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球藥物篩檢市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 藥物篩檢市場：競爭格局及市場佔有率（2024年）
• 藥物篩檢市場：公司估值矩陣
• 藥物篩檢市場：公司概況
  • Laboratory Corporation
  • Quest Diagnostics Incorporated
  • OraSure Technologies Inc.
  • Alfa Scientific Designs Inc.
  • Abbott Laboratories

第37章：其他領先和創新企業

• Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年藥物篩檢市場：提供新機會的國家
• 2030年藥物篩檢市場：充滿新機會的細分領域
• 2030年藥物篩檢市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

Tariffs are impacting the drug screening market by increasing costs of imported reagents, assay kits, analytical instruments, sensors, and laboratory equipment. Diagnostic laboratories and law enforcement agencies in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces cost pressure on test kit manufacturing. These tariffs are raising testing costs and procurement challenges. However, they are also encouraging domestic reagent production, localized kit assembly, and innovation in cost-efficient drug screening solutions.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $9.72 billion in 2025 to $11.18 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing workplace drug testing programs, expansion of clinical trial activities, rising law enforcement screening requirements, growth of diagnostic laboratories, wider availability of rapid test kits.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $19.2 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled screening analytics, rising demand for portable drug testing devices, expansion of regulatory drug compliance testing, growing use of real-time reporting systems, innovation in multi-panel drug screening. Major trends in the forecast period include increasing adoption of rapid drug testing kits, rising use of automated laboratory screening systems, growing integration of digital reporting solutions, expansion of point-of-care drug testing, enhanced focus on high-accuracy detection.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. IFor instance, in June 2025, According to the United Nations Office on Drugs and Crime, a Austria based United Nations office, reported 316 million people used a drug (excluding alcohol and tobacco) in 2023, or six per cent of the population aged between 15 and 64,. With 244 million users, cannabis remains the most widely used drug, followed by opioids (61 million), amphetamines (30.7 million), cocaine (25 million) and "ecstasy" (21 million). New groups of vulnerable people fleeing hardship, instability and conflict could cause these numbers to increase further, the report warns. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

Companies operating in the drug screening market are increasingly emphasizing strategic partnerships and collaborations to strengthen financial capabilities, enhance product offerings, and expand geographic reach. A strategic collaboration involves an agreement between two or more independent organizations to jointly pursue defined objectives while maintaining operational autonomy. For example, in February 2025, Neopharma Technologies, a Canada-based drug testing company, and Impairment Science, a U.S.-based cognitive assessment company, announced a strategic partnership focused on advancing drug and impairment testing. The collaboration integrates Neopharma's NEOVAULT platform, which digitally interprets and reports rapid drug test results, with Impairment Science's DRUID cognitive impairment assessment, an AI-enabled tool designed to evaluate functional impairment. By combining these technologies, the partnership seeks to improve the precision and practical relevance of drug screening by delivering real-time insights into both substance detection and functional impairment. This initiative has the potential to enhance workplace safety, support regulatory compliance, and improve decision-making in safety-sensitive environments through the use of AI and digital reporting solutions.

In June 2024, Premier Biotech, a U.S.-based provider of urine and oral fluid drug testing solutions and toxicology services, acquired Desert Tox, LLC for an undisclosed amount. Through this acquisition, Premier Biotech seeks to expand its laboratory testing capabilities, reinforce its position in the oral-fluid drug testing market, and extend its national customer reach across workplace, government, and occupational health segments. Desert Tox, LLC is a U.S.-based company that delivers SAMHSA-certified urine and oral-fluid drug testing services to employment, government, and clinical clients.

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
• 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
• 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
• Subsegments:
• 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
• 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
• 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
• Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Dragerwerk AG & Co. KGaA; LifeLoc Technologies Inc.; MPD Inc.; Omega Laboratories Inc.; Premier Biotech Inc.; Psychemedics Corporation; F. Hoffmann-La Roche Ltd.; Shimadzu Corporation; Siemens Healthineers AG; Medtox Scientific Inc.; American Screening Corporation; Clinical Reference Laboratory Inc.; Express Diagnostics International Inc.; Global Drug Testing Services; Kroll Laboratory Specialists Inc.; Medscreen Laboratories; National Screening Centers Inc.; American Bio Medica Corporation; Mayo Clinic Laboratories; ACM Global Laboratories; Intertek Group plc; Eurofins Scientific SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Drug Screening Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Drug Screening Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Drug Screening Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Drug Screening Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Rapid Drug Testing Kits
  • 4.2.2 Rising Use Of Automated Laboratory Screening Systems
  • 4.2.3 Growing Integration Of Digital Reporting Solutions
  • 4.2.4 Expansion Of Point-Of-Care Drug Testing
  • 4.2.5 Enhanced Focus On High-Accuracy Detection

5. Drug Screening Market Analysis Of End Use Industries

• 5.1 Drug Testing Laboratories
• 5.2 Workplaces
• 5.3 Hospitals
• 5.4 Law Enforcement Agencies
• 5.5 Drug Treatment Centers

6. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Drug Screening Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Drug Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Drug Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Screening Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Screening Market Segmentation

• 9.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rapid Testing Devices, Consumables, Other Products
• 9.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
• 9.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges
• 9.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
• 9.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Reagents and Assays, Sample Collection Devices, Calibration Standards
• 9.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Equipment, Software Solutions, Storage and Transport Solutions

10. Drug Screening Market Regional And Country Analysis

• 10.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Screening Market

• 11.1. Asia-Pacific Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Screening Market

• 12.1. China Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Screening Market

• 13.1. India Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Screening Market

• 14.1. Japan Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Screening Market

• 15.1. Australia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Screening Market

• 16.1. Indonesia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Screening Market

• 17.1. South Korea Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Screening Market

• 18.1. Taiwan Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Screening Market

• 19.1. South East Asia Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Screening Market

• 20.1. Western Europe Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Screening Market

• 21.1. UK Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Screening Market

• 22.1. Germany Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Screening Market

• 23.1. France Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Screening Market

• 24.1. Italy Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Screening Market

• 25.1. Spain Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Screening Market

• 26.1. Eastern Europe Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Screening Market

• 27.1. Russia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Screening Market

• 28.1. North America Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Screening Market

• 29.1. USA Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Screening Market

• 30.1. Canada Drug Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Screening Market

• 31.1. South America Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Screening Market

• 32.1. Brazil Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Screening Market

• 33.1. Middle East Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Screening Market

• 34.1. Africa Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Screening Market Regulatory and Investment Landscape

36. Drug Screening Market Competitive Landscape And Company Profiles

• 36.1. Drug Screening Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Drug Screening Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Drug Screening Market Company Profiles
  • 36.3.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Drug Screening Market Other Major And Innovative Companies

• Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services

38. Global Drug Screening Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Screening Market

40. Drug Screening Market High Potential Countries, Segments and Strategies

• 40.1 Drug Screening Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Drug Screening Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Drug Screening Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer